Uterine Cancer Clinical Trials 2022

Uterine Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect uterine cancer clinical trial in 2022.

Condition

Location

Distance

Age

Clinical Trials Uterine Cancer Clinical Trials 2022

Phase-Based Progress Estimates

Survey Administrationfor Cancer of Uterus

New Brunswick, NJ

New Brunswick, NJ

This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.

Phase-Based Progress Estimates

MDNA11 Monotherapyfor Melanoma

Locally Advanced

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

Phase-Based Progress Estimates

Hypofractionationfor Endometrial Cancer

Toronto, Canada

Toronto, Canada

This study is evaluating whether hypofractionated radiation therapy is as effective as conventional radiation therapy in reducing the risk of local recurrence in uterine cancers.

Phase-Based Progress Estimates

SBRTfor Endometrial Neoplasms

Toronto, Canada

Waitlist Available

Toronto, Canada

This study is evaluating whether a radiation dose of 30 Gy in 5 fractions is safe and well tolerated for people with endometrial cancer.

Phase-Based Progress Estimates

Fulvestrantfor Carcinoma, Non-Small-Cell Lung

Locally Advanced

This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or cannot be removed completely with surgery (unresectable). All participants will get both tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get a drug called fulvestrant. The trial will also look at what side effects happen. A side effect is anything a drug does besides treating cancer.

Phase-Based Progress Estimates

Triapinefor Endometrial Serous Adenocarcinoma

Philadelphia, PA

Philadelphia, PA

This study is evaluating whether triapine is safe for people with uterine cancer.

Phase-Based Progress Estimates

Hemp-based CBDfor Breast Cancer

This study is evaluating whether a hemp-based cannabidiol (CBD) product may help reduce the severity and duration of chemotherapy-induced neuropathy (CIPN) among non

Phase-Based Progress Estimates

Seribantumabfor Prostate Cancer

Locally Advanced

This study is evaluating whether a drug which targets a gene fusion may help treat cancer.

Phase-Based Progress Estimates

Mitomycinfor Cancer, Appendiceal

This study is evaluating whether a minimally invasive procedure

Phase-Based Progress Estimates

Sacral Nerve Stimulatorfor Fecal Soiling

Locally Advanced

This study is evaluating whether a surgery which stimulates nerves in the lower back may help treat fecal incontinence.

Phase-Based Progress Estimates

AZD1775for Carcinosarcoma

Locally Advanced

This research study is studying an investigational drug as a possible treatment for uterine cancer. The drug involved in this study is: -AZD1775

Phase-Based Progress Estimates

Fulvestrantfor Adenocarcinoma of Endometrium

1 Prior Treatment

This study is evaluating whether a combination of two drugs may help treat breast cancer.

Phase-Based Progress Estimates

NEO-201 In Combination With Pembrolizumabfor Adenocarcinoma of Lung

This study is evaluating whether a new drug may help treat cancer.

Phase-Based Progress Estimates

External Beam Radiation Therapyfor Endometrioid Adenocarcinoma

Waitlist Available

This study is evaluating the side effects and best dose of adavosertib when given together with external beam radiation therapy and cisplatin in treating patients with cervical, vaginal, or uterine cancer.

Phase-Based Progress Estimates

Stereotactic Body Radiation Therapyfor Cystadenocarcinoma, Serous

Waitlist Available

This study is evaluating whether stereotactic body radiation therapy is safe and effective in treating patients with ovarian or uterine cancer that has come back.

Phase-Based Progress Estimates

Nivolumabfor Carcinosarcoma

Waitlist Available

Locally Advanced

This study is evaluating whether a drug may help prevent cancer in women with a history of cancer.

Phase-Based Progress Estimates

Atezolizumabfor Cancer of Uterus

Waitlist Available

Locally Advanced

This study is evaluating whether a drug called Vigil can be safely given to patients who have tumor harvested at surgery and successful manufacturing of Vigil but are ineligible for CL-PTL-119 (the VITAL study) or previously randomized to placebo, and also in patients who have recurrent ovarian cancer.

Phase-Based Progress Estimates

Image-Guided Brachytherapyfor Vaginal Cancers

This study is evaluating whether MRI can help doctors better target radiation therapy for gynecologic cancers.

Phase-Based Progress Estimates

Metformin Hydrochloridefor Breast Cancer

Philadelphia, PA

Waitlist Available

Newly Diagnosed

Philadelphia, PA

This study is evaluating whether a combination of two drugs may be more effective than either drug alone in treating patients with localized breast or uterine cancer.

Phase-Based Progress Estimates

Crizotinibfor Lymphoma

This study is evaluating whether genetic testing may help determine the best treatment for patients with solid tumors or lymphomas.

Phase-Based Progress Estimates

Bevacizumabfor Neoplastic Syndromes, Hereditary

Waitlist Available

This study is evaluating whether a combination of drugs can be used to treat kidney cancer.

Phase-Based Progress Estimates

Audio + Radio (AURA)for Ovarian Cancer

Chapel Hill, NC

Chapel Hill, NC

This is a proof-of-concept pilot randomized clinical trial to test the usability and feasibility of the innovative Audio + Radio (AURA) system to enhance personalized supportive care for cancer patients and caregivers during post-ostomy care transition.

Phase-Based Progress Estimates

Pembrolizumabfor Mixed Tumor, Mullerian

Rockville Centre, NY

Locally Advanced

Rockville Centre, NY

The purpose of this study to find out whether the combination of lenvatinib and pembrolizumab is an effective treatment for advanced uterine carcinosarcoma. The researchers will also do tests to find out whether biomarkers in the blood can predict the cancer's response to the study treatment. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service